Dr Andrew Rut: Opportunities and challenges for drug safety in Japan


The Japanese pharmaceuticals market has undergone significant shakeup in recent years, now reaching new leagues as the third biggest pharmaceuticals market in the world.

In a recent article with Pharma Business International, Dr Andrew Rut, CEO and co-founder of MyMeds&Me, discusses the opportunities and challenges of drug safety in Japan in the face of market growth and regulatory change.

Read the article here

Request More Information

To find out more or request a demo fill in the details below:

For more information contact chris.beverley@mymedsandme.com

Keep informed

For expert insight and updates from the MyMeds&Me team.

We respect your privacy and we will only use your email address for newsletters and company updates